No Data
No Data
State Street Corp's Strategic Reduction in Altimmune Inc Holdings
Altimmune, Inc. (ALT): A Bull Case Theory
Millennium Management LLC Increases Stake in Altimmune Inc
Altimmune Call Volume Above Normal and Directionally Bullish
Altimmune to Present New Data on the Lipidomic Profile in Subjects Treated With Pemvidutide at The Liver Meeting 2024
Novo Nordisk, Eli Lilly Could Face Downward Pressure Despite Market Dominance From Potentially 16 New Obesity Drugs: See The Names